Literature DB >> 32559135

Acute and chronic sympathomimetic effects of e-cigarette and tobacco cigarette smoking: role of nicotine and non-nicotine constituents.

Sara Arastoo1, Kacey P Haptonstall1, Yasmine Choroomi1, Roya Moheimani1, Kevin Nguyen1, Elizabeth Tran1, Jeffrey Gornbein2, Holly R Middlekauff1.   

Abstract

Electronic cigarettes (ECs) and tobacco cigarettes (TCs) both release nicotine, a sympathomimetic drug. We hypothesized that baseline heart rate variability (HRV) and hemodynamics would be similar in chronic EC and TC smokers and that after acute EC use, changes in HRV and hemodynamics would be attributable to nicotine, not non-nicotine, constituents in EC aerosol. In 100 smokers, including 58 chronic EC users and 42 TC smokers, baseline HRV and hemodynamics [blood pressure (BP) and heart rate (HR)] were compared. To isolate the acute effects of nicotine vs. non-nicotine constituents in EC aerosol, we compared changes in HRV, BP, and HR in EC users after using an EC with nicotine (ECN), EC without nicotine (EC0), nicotine inhaler (NI), or sham vaping (control). Outcomes were also compared with TC smokers after smoking one TC. Baseline HRV and hemodynamics were not different in chronic EC users and TC smokers. In EC users, BP and HR, but not HRV outcomes, increased only after using the ECN, consistent with a nicotine effect on BP and HR. Similarly, in TC smokers, BP and HR but not HRV outcomes increased after smoking one TC. Despite a similar increase in nicotine, the hemodynamic increases were significantly greater after TC smokers smoked one TC compared with the increases after EC users used the ECN. In conclusion, chronic EC and TC smokers exhibit a similar pattern of baseline HRV. Acute increases in BP and HR in EC users are attributable to nicotine, not non-nicotine, constituents in EC aerosol. The greater acute pressor effects after TC compared with ECN may be attributable to non-nicotine, combusted constituents in TC smoke.NEW & NOTEWORTHY Chronic electronic cigarette (EC) users and tobacco cigarette (TC) smokers exhibit a similar level of sympathetic nerve activity as estimated by heart rate variability. Acute increases in blood pressure (BP) and heart rate in EC users are attribute to nicotine, not non-nicotine, constituents in EC aerosol. Acute TC smoking increased BP significantly more than acute EC use, despite similar increases in plasma nicotine, suggestive of additional adverse vascular effects attributable to combusted, non-nicotine constituents in TC smoke.

Entities:  

Keywords:  blood pressure; electronic cigarettes; heart rate variability; nicotine; tobacco cigarettes

Mesh:

Substances:

Year:  2020        PMID: 32559135      PMCID: PMC7473924          DOI: 10.1152/ajpheart.00192.2020

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   5.125


  42 in total

1.  Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology.

Authors: 
Journal:  Eur Heart J       Date:  1996-03       Impact factor: 29.983

Review 2.  Stress Cardiomyopathy Diagnosis and Treatment: JACC State-of-the-Art Review.

Authors:  Horacio Medina de Chazal; Marco Giuseppe Del Buono; Lori Keyser-Marcus; Liangsuo Ma; F Gerard Moeller; Daniel Berrocal; Antonio Abbate
Journal:  J Am Coll Cardiol       Date:  2018-10-16       Impact factor: 24.094

3.  Heart rate variability and first cardiovascular event in populations without known cardiovascular disease: meta-analysis and dose-response meta-regression.

Authors:  Stefanie Hillebrand; Karin B Gast; Renée de Mutsert; Cees A Swenne; J Wouter Jukema; Saskia Middeldorp; Frits R Rosendaal; Olaf M Dekkers
Journal:  Europace       Date:  2013-01-30       Impact factor: 5.214

4.  Effects of smoking cessation on heart rate variability among long-term male smokers.

Authors:  Christopher B Harte; Cindy M Meston
Journal:  Int J Behav Med       Date:  2014-04

5.  Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators.

Authors:  M T La Rovere; J T Bigger; F I Marcus; A Mortara; P J Schwartz
Journal:  Lancet       Date:  1998-02-14       Impact factor: 79.321

6.  Pharmacodynamics of acute tolerance to multiple nicotinic effects in humans.

Authors:  K Fattinger; D Verotta; N L Benowitz
Journal:  J Pharmacol Exp Ther       Date:  1997-06       Impact factor: 4.030

7.  Mechanisms responsible for sympathetic activation by cigarette smoking in humans.

Authors:  G Grassi; G Seravalle; D A Calhoun; G B Bolla; C Giannattasio; M Marabini; A Del Bo; G Mancia
Journal:  Circulation       Date:  1994-07       Impact factor: 29.690

8.  Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study.

Authors:  H Tsuji; M G Larson; F J Venditti; E S Manders; J C Evans; C L Feldman; D Levy
Journal:  Circulation       Date:  1996-12-01       Impact factor: 29.690

9.  A pilot study of nicotine delivery to smokers from a metered-dose inhaler.

Authors:  Brent Caldwell; Stuart Dickson; Carl Burgess; Robert Siebers; Sima Mala; Adrienne Parkes; Julian Crane
Journal:  Nicotine Tob Res       Date:  2009-04-03       Impact factor: 4.244

10.  Increased Cardiac Sympathetic Activity and Oxidative Stress in Habitual Electronic Cigarette Users: Implications for Cardiovascular Risk.

Authors:  Roya S Moheimani; May Bhetraratana; Fen Yin; Kacey M Peters; Jeffrey Gornbein; Jesus A Araujo; Holly R Middlekauff
Journal:  JAMA Cardiol       Date:  2017-03-01       Impact factor: 30.154

View more
  2 in total

1.  Angiotensin II type 1 receptor mediates pulmonary hypertension and right ventricular remodeling induced by inhaled nicotine.

Authors:  Nicholas D Fried; Tamara M Morris; Anna Whitehead; Eric Lazartigues; Xinping Yue; Jason D Gardner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-02-12       Impact factor: 4.733

Review 2.  Electronic Cigarette Use and Metabolic Syndrome Development: A Critical Review.

Authors:  Ilona Górna; Marta Napierala; Ewa Florek
Journal:  Toxics       Date:  2020-11-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.